Characterisation of a recombinant P2Y purinoceptor

https://doi.org/10.1016/0922-4106(95)90068-3Get rights and content

Abstract

We have previously cloned a cDNA encoding a G-protein-coupled P2 purinoceptor from chick brain and designated this as a P2Y1 purinoceptor (Webb, T.E., J. Simon, B.J. Krishek, A.N. Bateson, T.G. Smart, B.J. King, G. Burnstock and E.A. Barnard, 1993, FEBS Lett. 324, 219). Here, we describe the further characterisation of this recombinant receptor expressed in both simian kidney endothelial (COS-7) cells and Xenopus oocytes. In transfected COS-7 cell membranes, the recombinant receptor showed a high level of expression (Bmax = 7.9 ± 2.2 pmol [35S]dATPαS bound/mg protein) and affinity (Kd = 6.6 ± 0.3 nM). In these COS-7 cells, the activation of the implanted purinoceptor induced a suramin-sensitive formation of inositol 1,4,5-triphosphate (1,4,5InsP3). Upon expression in Xenopus oocytes, ATP was the only natural nucleoside triphosphate to elicit a Ca2+-activated chloride current. The P2 purinoceptor antagonists suramin and Reactive Blue-2 were both able to inhibit this evoked current. Utilizing both expression systems, the binding affinity profile and the functional pharmacological profile of the agonists, the common series found was: 2-methylthioATP (2-MeSATP) ⩾ ATP > ADPβS > ADP. These two agonist series and the lack of activity of adenosine, α,β-methyleneATP (α,β-meATP), 3′-O-(4- benzoyl)benzoyl-ATP (Bz-ATP) and UTP, together confirmed that this receptor is a specific subtype of the P2Y purinoceptors.

References (45)

  • F.A. Edwards et al.

    ATP — a fast neurotransmitter

    FEBS Lett.

    (1993)
  • F. Fournier et al.

    Ins(1,4,5)P3 formation and fluctuating chloride current response induced by external ATP in Xenopus oocytes injected with embryonic guinea-pig brain mRNA

    FEBS Lett.

    (1990)
  • S. Keppens

    The complex interaction of ATP and UTP with isolated hepatocytes. How many receptors?

    Gen. Pharmacol.

    (1993)
  • E.M. Landau et al.

    Chloride current assay for phospholipase C in Xenopus oocytes

    Methods Enzymol.

    (1994)
  • P.J. Munson et al.

    A versatile computerized approach for the characterisation of ligand binding systems

    Anal. Biochem.

    (1980)
  • A.J. Murgo et al.

    Evidence for separate calcium signaling P2T and P2U purinoceptors in human megakariotic Dami cells

    Blood

    (1994)
  • S.E. O'Connor et al.

    Further subclassification of ATP receptors based on agonist studies

    Trends Pharmacol. Sci.

    (1991)
  • T.E. Webb et al.

    Cloning and functional expression of a cDNA encoding a brain P2Y purinoceptor

    FEBS Lett.

    (1993)
  • L.A. Welford et al.

    The structure-activity relationship of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency

    Eur. J. Pharmacol.

    (1987)
  • D. Wu et al.

    Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by alpha subunits of Gq family

    J. Biol. Chem.

    (1992)
  • T.G.J. Allen et al.

    The actions of adenosine 5′ triphosphate on guinea-pig intracardiac neurones in culture

    Br. J. Pharmacol.

    (1990)
  • R. Boton et al.

    Inactivation of calcium-activated chloride conductance in Xenopus oocytes: roles of calcium and protein kinase C.

    Pflüg. Arch.

    (1990)
  • Cited by (82)

    • P2X3 receptors participate in purinergic inhibition of gastrointestinal smooth muscle

      2021, Autonomic Neuroscience: Basic and Clinical
      Citation Excerpt :

      The P2Y1 receptor is a membrane-inserted heptahelical protein which couples to a heterotrimeric G-protein (Gq/11) and raises the activity of the intracellular signalling enzyme phospholipase C (PLCβ) when expressed in host cells. In turn, PLCβ generates inositol trisphosphate (IP3) and afterwards IP3 releases Ca2+ from intracellular stores (Webb et al., 1993; Filtz et al., 1994; Simon et al., 1995). Inhibitory P2Y1 receptors in the gut work through the same Gqα/PLCβ/IP3/Ca2+i signalling pathway which leads to the downstream activation of Ca2+-dependent and apamin-sensitive K+-channels (KCa, SK-type), followed afterwards by the closure of voltage-sensitive Ca2+-channels (CaV, L-type) and the relaxation of smooth muscle tone (Beyder and Farrugia, 2012; Goyal et al., 2013; Burnstock, 2014; Sanders et al., 2014; Kennedy, 2015; King, 2015, 2021; Mader et al., 2016).

    • Purinergic signalling in the enteric nervous system (An overview of current perspectives)

      2015, Autonomic Neuroscience: Basic and Clinical
      Citation Excerpt :

      The originally-defined pharmacological profile for P2Y receptors gave an agonist potency order of 2-MeSATP > > ATP > α,β-meATP for NANC relaxations in guinea-pig taenia coli (Burnstock and Kennedy, 1985). 2-MeSATP and ATP are agonists at recombinant P2Y1 receptors but, perplexingly, α,β-meATP is ineffective (Webb et al., 1993; Burnstock et al., 1994; Filtz et al., 1994; Simon et al., 1995; Tokuyama et al., 1995). However, α,β-meATP is a potent stimulant at some P2X ion-channels found in the ENS (Galligan and North, 2004; Burnstock, 2014).

    View all citing articles on Scopus
    1

    Present address: Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, UK.

    View full text